Heron Therapeutics Inc. (HRTX) Statistics & Valuation Metrics - Stocknear

Heron Therapeutics Inc.

NASDAQ: HRTX · Real-Time Price · USD
1.31
-0.01 (-0.76%)
At close: Sep 05, 2025, 3:59 PM
1.32
0.76%
After-hours: Sep 05, 2025, 05:38 PM EDT

Heron Therapeutics Statistics

Share Statistics

Heron Therapeutics has 153.29M shares outstanding. The number of shares has increased by 0.59% in one year.

153.29M
0.59%
0.15%
81.29%
151.81M
1
n/a

Short Selling Information

The latest short interest is 33.23M, so 21.68% of the outstanding shares have been sold short.

33.23M
21.68%
28.15%
10.56

Valuation Ratios

The PE ratio is -17.18 and the forward PE ratio is 22. Heron Therapeutics's PEG ratio is 0.19.

-17.18
22
1.62
1.1
-6.93
-9.62
0.19
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Heron Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 2.29, with a Debt / Equity ratio of -5.28.

2.29
1.7
-5.28
-35.16
-7.33
-1.91

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$1.18M
$-111.31K
122
0.62
0.73

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -27.22% in the last 52 weeks. The beta is 1.23, so Heron Therapeutics's price volatility has been higher than the market average.

1.23
-27.22%
1.73
1.84
34.65
1,691,158

Income Statement

In the last 12 months, Heron Therapeutics had revenue of 144.28M and earned -13.58M in profits. Earnings per share was -0.09.

144.28M
105.64M
-11.53M
-13.58M
-5.06M
-7.55M
-0.09
Full Income Statement

Balance Sheet

The company has 25.8M in cash and 177.76M in debt, giving a net cash position of -151.96M.

25.8M
177.76M
-151.96M
-1.92B
232.09M
-47.68M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -22.53M and capital expenditures -1.71M, giving a free cash flow of -24.23M.

-22.53M
-1.71M
-24.23M
-0.16
Full Cash Flow Statement

Margins

Gross margin is 73.21%, with operating and profit margins of -7.99% and -9.41%.

73.21%
-7.99%
-9.41%
-9.41%
-3.5%
-7.99%
-16.8%

Dividends & Yields

HRTX does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for HRTX is $4.5, which is 243.5% higher than the current price. The consensus rating is "Buy".

$4.5
243.5%
Buy
2
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Jan 13, 2014. It was a backward split with a ratio of 1:20.

Jan 13, 2014
backward
1:20

Scores

-10.64
3